100 millionth person receives lifesaving meningitis vaccine
On 3 December, a revolutionary and affordable meningitis vaccine, MenAfriVac®, reached the 100 millionth person in a region of Africa that has been plagued by deadly epidemics for more than a century. MenAfriVac® vaccine was first launched in Burkina Faso. Since then, nine other countries have held vaccination campaigns to protect people from ages 1 to 29 against meningitis A. The vaccine has already significantly reduced the burden of meningitis in the regions where it has been introduced.